H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Census population 189,692. Rhode Island Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Providence clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Providence storefront.
Non-Surgical Regenerative Therapy Options in Providence, RI for clinics & physicians. Give patients non-su… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure. Census city-proper population is 189,692. If you are adding non surgical regenerative therapy, start with that epidemiology and with National Government Services (NGS) (JK) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Non-Surgical Regenerative Therapy Options notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Providence we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 11.5% of adults in Providence have diagnosed diabetes — 0.5 points below the U.S. 12% figure.
If you already buy non surgical regenerative therapy elsewhere, use this page as a check: homologous-use language, current National Government Services (NGS) article IDs, and PLACES 11.5% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 11.5% of adults — 0.5 points below the U.S. 12% figure. Obesity is 34.4%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Providence trial.
Rhode Island is in CMS MAC JK, administered by National Government Services (NGS). CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Regulatory lane, storage, and JK coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
If you operate in Rhode Island and another MAC state, say it on the first call. JK will not port 1:1. We would rather split utilization than watch a sister clinic copy Providence tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Providence, RI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Providence is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Providence — 0.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Rhode Island Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, NY, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Providence. Useful for joint-program math; still needs a diagnosis and privileging.
No Providence storefront. Joe Bradley is an active practice owner. non surgical regenerative therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.